These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23576314)

  • 1. Conformation and atropisomeric properties of indometacin derivatives.
    Wakamatsu S; Takahashi Y; Tabata H; Oshitari T; Tani N; Azumaya I; Katsumoto Y; Tanaka T; Hosoi S; Natsugari H; Takahashi H
    Chemistry; 2013 May; 19(22):7056-63. PubMed ID: 23576314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atropisomerism observed in indometacin derivatives.
    Takahashi H; Wakamatsu S; Tabata H; Oshitari T; Harada A; Inoue K; Natsugari H
    Org Lett; 2011 Feb; 13(4):760-3. PubMed ID: 21250752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A complete gear system in N-benzoyl-carbazole derivatives.
    Tabata H; Kayama S; Takahashi Y; Tani N; Wakamatsu S; Tasaka T; Oshitari T; Natsugari H; Takahashi H
    Org Lett; 2014 Mar; 16(5):1514-7. PubMed ID: 24564505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.
    Arisawa M; Kasaya Y; Obata T; Sasaki T; Nakamura T; Araki T; Yamamoto K; Sasaki A; Yamano A; Ito M; Abe H; Ito Y; Shuto S
    J Med Chem; 2012 Sep; 55(18):8152-63. PubMed ID: 22916727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX inhibitors Indomethacin and Sulindac derivatives as antiproliferative agents: synthesis, biological evaluation, and mechanism investigation.
    Chennamaneni S; Zhong B; Lama R; Su B
    Eur J Med Chem; 2012 Oct; 56():17-29. PubMed ID: 22940705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atropisomeric myristinins: selective COX-2 inhibitors and antifungal agents from Myristica cinnamomea.
    Sawadjoon S; Kittakoop P; Kirtikara K; Vichai V; Tanticharoen M; Thebtaranonth Y
    J Org Chem; 2002 Aug; 67(16):5470-5. PubMed ID: 12153244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors.
    Lau CK; Black WC; Belley M; Chan C; Charleson S; Denis D; Gauthier JY; Gordon R; Guay D; Hamel P; Kargman S; Leblanc Y; Mancini J; Ouellet M; Percival D; Prasit P; Roy P; Skorey K; Tagari P; Vickers P; Wong E
    Adv Exp Med Biol; 1997; 407():73-8. PubMed ID: 9321934
    [No Abstract]   [Full Text] [Related]  

  • 8. Indolyl esters and amides related to indomethacin are selective COX-2 inhibitors.
    Kalgutkar AS; Crews BC; Saleh S; Prudhomme D; Marnett LJ
    Bioorg Med Chem; 2005 Dec; 13(24):6810-22. PubMed ID: 16169736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors.
    Khanna S; Madan M; Vangoori A; Banerjee R; Thaimattam R; Jafar Sadik Basha SK; Ramesh M; Casturi SR; Pal M
    Bioorg Med Chem; 2006 Jul; 14(14):4820-33. PubMed ID: 16581252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereoselective binding of indomethacin ethanolamide derivatives to cyclooxygenase-1.
    Moth CW; Prusakiewicz JJ; Marnett LJ; Lybrand TP
    J Med Chem; 2005 May; 48(10):3613-20. PubMed ID: 15887968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization-induced diastereomeric transformation of N-2'-t-butyl-6'-iodobenzoyl-3-bromocarbazole.
    Kayama S; Tani N; Takahashi Y; Tabata H; Wakamatsu S; Oshitari T; Natsugari H; Takahashi H
    Chem Pharm Bull (Tokyo); 2014; 62(8):836-8. PubMed ID: 25087637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Atropisomeric Properties of Benzoazepine-Fused Isoindoles.
    de Ceuninck van Capelle LA; Wales SM; Macdonald JM; Kruger M; Richardson C; Gardiner MG; Hyland CJT
    J Org Chem; 2023 Jul; 88(13):8738-8750. PubMed ID: 37326851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semipreparative HPLC enantioseparation, chiroptical properties, and absolute configuration of two novel cyclooxygenase-2 inhibitors.
    Cirilli R; Fiore S; La Torre F; Maccioni E; Secci D; Sanna ML; Faggi C
    Chirality; 2010 Jan; 22(1):56-62. PubMed ID: 19319987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of indomethacin analogues for evaluation as modulators of MRP activity.
    Maguire AR; Plunkett SJ; Papot S; Clynes M; O'Connor R; Touhey S
    Bioorg Med Chem; 2001 Mar; 9(3):745-62. PubMed ID: 11310610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 1,3-diphenylprop-2-en-1-ones possessing a methanesulfonamido or an azido pharmacophore as cyclooxygenase-1/-2 inhibitors.
    Zarghi A; Zebardast T; Hakimion F; Shirazi FH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Oct; 14(20):7044-50. PubMed ID: 16798002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of subtype-selective cyclooxygenase (COX) inhibitors derived from thalidomide.
    Sano H; Noguchi T; Tanatani A; Hashimoto Y; Miyachi H
    Bioorg Med Chem; 2005 May; 13(9):3079-91. PubMed ID: 15809144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atropisomeric properties of the dibenzo[b,d]azepin-6-one nucleus.
    Tabata H; Akiba K; Lee S; Takahashi H; Natsugari H
    Org Lett; 2008 Nov; 10(21):4871-4. PubMed ID: 18841991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of new 1,3-benzthiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Zebardast T; Daraie B; Hedayati M
    Bioorg Med Chem; 2009 Aug; 17(15):5369-73. PubMed ID: 19596198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and biological evaluation of indole-2 and 3-carboxamides: new selective cyclooxygenase-2 inhibitors.
    Olgen S; Güner E; Fabregat MA; Crespo MI; Nebioğlu D
    Pharmazie; 2002 Apr; 57(4):238-42. PubMed ID: 11998441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies.
    Huang Z; Velázquez CA; Abdellatif KR; Chowdhury MA; Reisz JA; DuMond JF; King SB; Knaus EE
    J Med Chem; 2011 Mar; 54(5):1356-64. PubMed ID: 21280601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.